Cinclus Pharma Holding Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Christer Ahlberg
Chief executive officer
SEK 5.2m
Total compensation
| CEO salary percentage | 67.1% |
| CEO tenure | 4yrs |
| CEO ownership | 0.2% |
| Management average tenure | 3.5yrs |
| Board average tenure | 9yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -SEK 158m |
| Jun 30 2024 | n/a | n/a | -SEK 183m |
| Mar 31 2024 | n/a | n/a | -SEK 203m |
| Dec 31 2023 | SEK 5m | SEK 3m | -SEK 215m |
| Dec 31 2022 | SEK 5m | SEK 4m | -SEK 249m |
| Dec 31 2021 | SEK 4m | SEK 2m | -SEK 76m |
Compensation vs Market: Christer's total compensation ($USD469.57K) is about average for companies of similar size in the German market ($USD463.54K).
Compensation vs Earnings: Christer's compensation has been consistent with company performance over the past year.
CEO
Christer Ahlberg (53 yo)
4yrs
Tenure
SEK 5,182,000
Compensation
Mr. Christer Ahlberg serves as the Chief Executive Officer & President of Cinclus Pharma Holding AB Since 2021. He served as a Director at PMD Device Solutions AB since 2021 until 2024. He served as Direct...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-founder & Chairman of the Board | 11yrs | SEK 494.00k | 2.23% € 1.7m | |
| CEO & President | 4yrs | SEK 5.18m | 0.17% € 128.4k | |
| Co-founder & Director | no data | SEK 2.28m | 4.35% € 3.2m | |
| Chief Financial Officer | 4yrs | no data | 0.017% € 12.8k | |
| Director of Corporate & Business Development | 1yr | no data | no data | |
| Chief Medical Officer | 3yrs | no data | no data |
3.5yrs
Average Tenure
56.5yo
Average Age
Experienced Management: J8P's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-founder & Chairman of the Board | 11yrs | SEK 494.00k | 2.23% € 1.7m | |
| Co-founder & Director | 11yrs | SEK 2.28m | 4.35% € 3.2m | |
| Independent Director | 4yrs | SEK 290.00k | 0.10% € 75.1k | |
| Independent Director | 8yrs | SEK 329.00k | 0.19% € 140.1k | |
| Independent Director | 3yrs | SEK 265.00k | no data | |
| Independent Director | 9yrs | SEK 265.00k | 0.045% € 33.4k | |
| Independent Director | 9yrs | SEK 240.00k | 0.020% € 15.3k |
9.0yrs
Average Tenure
67yo
Average Age
Experienced Board: J8P's board of directors are considered experienced (9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/30 23:52 |
| End of Day Share Price | 2025/01/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cinclus Pharma Holding AB (publ) is covered by 2 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Oscar Haffen Lamm | Bryan Garnier & Co |
| Kevin Sule | Redeye |